相关实验视频
Updated: Jul 17, 2025

Assessing Respiratory Immune Responses to Haemophilus Influenzae
Published on: June 29, 2021
在一个两个月大的婴儿中,Hemophilus Influenzae Empyema 在一个两个月大的婴儿中
Saif Al-Yazeedi1, Rima Al-Farsi2, Hatem Al-Rawahi3,4
1Medical Laboratory Department, Yanqal Hospital, Yanqul, Oman.
新生儿肺,一种罕见的肺炎并发症,具有很高的风险. 这一案例突显了在婴儿中使用手术和抗生素成功治疗Haemophilus influenzae empyema,从而完全康复.
科学领域:
- 儿童传染病 儿童传染病
- 新生儿重症监护中心新生儿重症监护中心
- 胸部外科手术 胸部外科手术
背景情况:
- 肺是新生儿肺炎的一种罕见但严重的并发症.
- 它与这一脆弱人群的显著发病率和死亡率有关.
- 及时诊断和有效管理至关重要.
研究的目的:
- 在新生儿中报告一种Hemophilus influenzae empyema病例.
- 描述所采用的成功管理策略.
- 强调适时干预新生儿 empyema 的重要性.
主要方法:
- 评估了一名两个月大的新生儿,出现了发烧,呼吸短促和饮食减少的症状.
- 诊断调查证实了Hemophilus influenzae empyema. 的存在.
- 治疗包括视频辅助胸腔镜手术和长时间的抗生素治疗.
主要成果:
- 新生儿在治疗后显示出完全的症状消失.
- 随访胸部X射线显示右胸部不透明度显著改善.
- 免疫工作结果处于正常范围内,表明没有潜在的免疫缺陷.
结论:
- 虽然罕见,但Haemophilus influenzae empyema可以在新生儿中成功管理.
- 手术干预和长期抗生素治疗的结合是有效的.
- 这一案例强调了早期诊断和跨学科护理对新生儿 empyema 的重要性.
更多相关视频
09:56Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation
Published on: March 2, 2016
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
相关概念视频
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Pneumonia II: Pathophysiology
Endocarditis I: Introduction
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.